Dave left because of the share price and the major dilution fears.
Board only get involved to steer the ship.
Dont get me wrong , impressed with Dave and the work he has put in.
The only consolation is that he gets the options for the next 12 months as if he was still employed.
Was paid his 2015 bonus which means the board acknowledge he did good but it was time for a change.
Meaning , that the company believes they should be at a much higher price range.
If we get cpulse2 expedited pathway , we will need more money than the approx $6m per quarter.
Sort out the financial aspect for the short term , then have an offering at 10 and get 60-70m which will last you till the end of 2017.
All this depends whether the company wants to sell soon or wait it out. If they want to sell soon , they will only sort out financing for the short term and wont think too far ahead.
Goldman sachs holding a few pct , st jude having observer rights , the ceo leaves , the stock price falls to an all time low , loan amended in favour of the company . something is going on behind the scenes.
Could you please explain the rights issue , what is the process and how do we benefit.
Add to My Watchlist
What is My Watchlist?